Product
BBC1501
1 clinical trial
1 indication
Indication
Age-related macular degenerationClinical trial
A Phase 1, Open Label, Ascending Dose Study to Evaluate the Safety of BBC1501 Administered by Intravitreal Injection for Neovascular Age-Related Macular Degeneration (nAMD)Status: Not yet recruiting, Estimated PCD: 2024-05-01